Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients
暂无分享,去创建一个
Y. Tomita | S. Fuchinoue | Y. Kato | K. Iwadoh | I. Nakajima | I. Koyama | K. Kitajima | K. Miki | Yuichi Ogawa | K. Kai | A. Sannomiya